- Home
- VERU vs CULP Comparison
VERU vs CULP Comparison
Compare VERU & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- CULP
- Stock Information
- Founded
- VERU 1971
- CULP 1972
- Country
- VERU United States
- CULP United States
- Employees
- VERU N/A
- CULP N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- CULP Textiles
- Sector
- VERU Health Care
- CULP Consumer Discretionary
- Exchange
- VERU Nasdaq
- CULP Nasdaq
- Market Cap
- VERU 54.6M
- CULP 52.7M
- IPO Year
- VERU 1990
- CULP N/A
- Fundamental
- Price
- VERU $2.88
- CULP $4.05
- Analyst Decision
- VERU Strong Buy
- CULP
- Analyst Count
- VERU 3
- CULP 0
- Target Price
- VERU $33.33
- CULP N/A
- AVG Volume (30 Days)
- VERU 182.9K
- CULP 14.7K
- Earning Date
- VERU 12-15-2025
- CULP 12-03-2025
- Dividend Yield
- VERU N/A
- CULP N/A
- EPS Growth
- VERU N/A
- CULP N/A
- EPS
- VERU N/A
- CULP N/A
- Revenue
- VERU $16,886,419.00
- CULP $207,391,000.00
- Revenue This Year
- VERU N/A
- CULP $1.93
- Revenue Next Year
- VERU N/A
- CULP $2.77
- P/E Ratio
- VERU N/A
- CULP N/A
- Revenue Growth
- VERU 337.24
- CULP N/A
- 52 Week Low
- VERU $2.64
- CULP $3.42
- 52 Week High
- VERU $14.20
- CULP $5.94
- Technical
- Relative Strength Index (RSI)
- VERU 32.50
- CULP 42.69
- Support Level
- VERU $2.76
- CULP $3.97
- Resistance Level
- VERU $3.99
- CULP $4.25
- Average True Range (ATR)
- VERU 0.29
- CULP 0.11
- MACD
- VERU -0.17
- CULP -0.01
- Stochastic Oscillator
- VERU 11.23
- CULP 34.21
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.